Program Strategy
- Program Strategy
  We provide comprehensive services to guide you through the development and execution of a program strategy, across all stages of development and life cycle management, for drugs, biologics, and medical devices.
  Overview
Clinical Trials
- Clinical Trials
  Our global solutions leverage decades of focused therapeutic expertise, strong site and investigator relationships and an insider’s understanding of international regulatory landscapes. Rho’s global team of experts ensure consistent trials—traditional, virtual, and hybrid—that run smarter and more efficiently.
Marketing Applications
- Marketing Applications
  Marketing application submissions, including NDAs, BLAs, and MAAs, are the culmination of years of research and the final hurdle before a product makes it to market. Let our integrated team of experts get your product across the finish line.
  Overview
Government Partnerships
Why Rho
- Why Rho
Resources
- Resources
Careers
- Careers

White paper

Understanding Right-to-Try and FDA’s Expanded Access

You may be familiar with Right-to-Try, but what does it actually mean for product sponsors? This white paper explores both Right-to-Try legislation and existing Expanded Access Programs, including:

Understanding sponsor responsibilities under these programs and when products may be eligible for these programs
Evaluating options such as treatment protocols, treatment INDs, and emergency use
Discussing development risks associated with participation in these programs